# ACD440 Gel in Peripheral Neuropathic Pain

> **NCT05416931** · PHASE2 · COMPLETED · sponsor: **AlzeCure Pharma** · enrollment: 14 (actual)

## Conditions studied

- Peripheral Neuropathic Pain

## Interventions

- **DRUG:** ACD440 Gel 14mg/g
- **DRUG:** Placebo Gel

## Key facts

- **NCT ID:** NCT05416931
- **Lead sponsor:** AlzeCure Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-20
- **Primary completion:** 2023-03-10
- **Final completion:** 2023-03-10
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2023-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05416931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05416931, "ACD440 Gel in Peripheral Neuropathic Pain". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05416931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*